ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

N,N-Dimethylglycine → 1-{4-[3-({1-[Bis-(4-chlorophenyl)methyl]azetidin-3-ylidene}methanesulfonylmethyl)phenyl]piperazin-1-yl}-2-dimethylaminoethanone

HRID 1058838
印刷

反応式

HRID 1058838 の反応式
CCN=C=NCCCN(C)C.[CH3:12][N:13]([CH3:18])[CH2:14][C:15](O)=[O:16].[Cl:19][C:20]1[CH:25]=[CH:24][C:23]([CH:26]([C:48]2[CH:53]=[CH:52][C:51]([Cl:54])=[CH:50][CH:49]=2)[N:27]2[CH2:30][C:29](=[CH:31][S:32]([CH2:35][C:36]3[CH:37]=[C:38]([N:42]4[CH2:47][CH2:46][NH:45][CH2:44][CH2:43]4)[CH:39]=[CH:40][CH:41]=3)(=[O:34])=[O:33])[CH2:28]2)=[CH:22][CH:21]=1>ClCCl>[Cl:19][C:20]1[CH:21]=[CH:22][C:23]([CH:26]([C:48]2[CH:49]=[CH:50][C:51]([Cl:54])=[CH:52][CH:53]=2)[N:27]2[CH2:28][C:29](=[CH:31][S:32]([CH2:35][C:36]3[CH:37]=[C:38]([N:42]4[CH2:47][CH2:46][N:45]([C:15](=[O:16])[CH2:14][N:13]([CH3:18])[CH3:12])[CH2:44][CH2:43]4)[CH:39]=[CH:40][CH:41]=3)(=[O:33])=[O:34])[CH2:30]2)=[CH:24][CH:25]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

5

反応物 3

HCID 673N,N-Dimethylglycine2 回HCID 159081-Ethyl-3-(3'-dimethylaminopropyl)carbodiimideHCID 696356951-[3-({1-[Bis-(4-chlorophenyl)methyl]azetidin-3-ylidene}methanesulfonylmethyl)phenyl]piperazine

生成物 1

HCID 186687351-{4-[3-({1-[Bis-(4-chlorophenyl)methyl]azetidin-3-ylidene}methanesulfonylmethyl)phenyl]piperazin-1-yl}-2-dimethylaminoethanone収率 84.8%

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒

実験手順

511 mg of supported EDCI (2.5 mM), 11.5 mg of N,N-dimethylglycine and then 5 cm3 of dichloromethane are successively added, at a temperature close to 20° C., to 54 mg of 1-[3-({1-[bis-(4-chlorophenyl)methyl]azetidin-3-ylidene}methanesulfonylmethyl)phenyl]piperazine. After stirring for 24 hours at a temperature close to 20° C., 35 mg of N,N-dimethylglycine are added. After stirring for 96 hours at a temperature close to 20° C., the reaction mixture is filtered on sintered glass. The resin is rinsed with three times 2.5 cm3 of dichloromethane. The combined filtrates are washed with 10 cm3 of water, dried over magnesium sulfate, filtered and concentrated to dryness under reduced pressure (5 kPa) at a temperature close to 20° C. 53 mg of 1-{4-[3-({1-[bis-(4-chlorophenyl)methyl]azetidin-3-ylidene}methanesulfonylmethyl)phenyl]piperazin-1-yl}-2-dimethylaminoethanone are thus obtained in the form of a beige foam [1H NMR spectrum (400 MHz, (CD3)2SO-d6, δ in ppm: 2.20 (s, 6H), 2.94 (s, 3H), 3.12 (s, 2H), 3.16 (mt, 4H), 3.58 (mt, 2H), 3.68 (mt, 2H), 3.80 (mt, 2H), 4.19 (mt, 2H), 4.78 (s, 1H), 6.81 (broad d, J=8 Hz, 1H), 6.93 (broad s, 1H), 6.99 (dd, J=8 and 2.5 Hz, 1H), 7.26 (t, J=8 Hz, 1H), 7.36 (d, J=8 Hz, 4H), 7.46 (d, J=8 Hz, 4H)].

後処理

  1. customclose to 20° C.
  2. stirringAfter stirring for 96 hours at a temperature
  3. customclose to 20° C.
  4. filtrationthe reaction mixture is filtered on sintered glass
  5. washThe resin is rinsed with three times 2.5 cm3 of dichloromethane
  6. washThe combined filtrates are washed with 10 cm3 of water
  7. dry with materialdried over magnesium sulfate
  8. filtrationfiltered
  9. concentrationconcentrated to dryness under reduced pressure (5 kPa) at a temperature
  10. customclose to 20° C

出典と根拠

ORDレコード
ord-7b75204d09744dd69f9b11c4c2913f2d
出典データセット
uspto-grants-2003_02
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US06518264B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート